Monro director awarded 11,149 restricted shares
Okray Thomas B reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Okray Thomas B reported acquisition or exercise transactions in this Form 4 filing.
Monro, Inc. director Thomas B. Okray reported an award of 11,149 shares of common stock on August 11, 2026. The award is in the form of restricted stock granted under the company’s Amended and Restated 2007 Stock Incentive Plan and carries no cash purchase price. Following this grant, Okray’s direct holdings total 24,392 shares. The restricted stock vests in three equal installments, one-third on each of the first three anniversaries of the grant date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 11,149 | $0.00 | $0.00 |
Footnotes (1)
- F1. This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the "Plan") and vests one-third on each of the three anniversaries of the grant date.
Key Figures
Key Terms
restricted stock financial
Amended and Restated 2007 Stock Incentive Plan financial
vests financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Monro, Inc. (MNRO) disclose for Thomas B. Okray?
Was the Monro, Inc. (MNRO) Form 4 transaction a purchase or a grant?
How does the restricted stock granted to the MNRO director vest?
Under which plan was the MNRO director’s restricted stock granted?
Does the Monro, Inc. (MNRO) Form 4 indicate any Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.